We got FDA approval for congestive haeart failure.
http://www.newswire.ca/en/releases/a...
Only a little excitement with the shares going up a few pennies today, but this the third of three important milestones the company has met this year. So we now have two major marketing agreements with the flu tests and a full slate of cardiovascular tests, not to mention the new improved Ramp 200 testing machine. 3M and Roche have the last ingedient for success and that is the marketing moxy to build world wide sales. This is obviously a buy situation for RBM shares.
~~ dimar